A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family
Salgado J., Aramendía J.M. [SP], Gutiérrez C., Gil C., Robles M., García-Foncillas J.
Clinical Genetics Unit, University Clinic of Navarra (CUN), Avda. Pío XII, 36, 31008, Pamplona, Navarra, Spain.
Magazine: Breast Cancer Research and Treatment
Date: Mar 1, 2009Medical Oncology Breast Cancer Area Clinical Genetics Unit [SP]
We report a novel germline 5369delATTT mutation in BRCA2 gene, detected in a 45-year-old woman with bilateral breast cancer.
This deletion was also detected in her father with prostatic cancer and her sister with breast cancer. The mutation originates a premature stop at codon 1723 of BRCA2 protein and has not been documented in any published report to the best of our knowledge.
CITATION Breast Cancer Res Treat. 2010 May;121(1):219-20
you mayBE INTERESTED
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.